Structures of the CCR5 N Terminus and of a Tyrosine-Sulfated Antibody with HIV-1 gp120 and CD4
The CCR5 co-receptor binds to the HIV-l gp120 envelope glycoprotein and facilitates HIV-l entry into cells. Its N terminus is tyrosine-sulfated, as are many antibodies that react with the co-receptor binding site on gp120. We applied nuclear magnetic resonance and crystallographic techniques to analyze the structure of the CCR5 N terminus and that of the tyrosine-sulfated antibody 412d in complex with gp120 and CD4. The conformations of tyrosine-sulfated regions of CCR5 (a-helix) and 412d (extendedloop) are surprisingly different. Nonetheless, a critical sulfotyrosine on CCR5 and on 412d induces similar structural rearrangements in gp120. These results now provide a framework for understanding HIV-l interactions with the CCR5 N terminus during viral entry and define a conserved site on gp120, whose recognition of sulfotyrosine engenders posttranslational mimicry by the immune system. E nUy of hwnan immunodeficiency virus type I (HIV-1) into host cells requires its gpl20 envelope glycoprotein to bind to two cell-surface receptors, CD4 and a coreceptor, either CCRS or CXCR4 [reviewed in (1, 2) ]. CCRS and CXCR4 are members of a family of chemokine receptors that are G protein-eoupled receptors (3) characterized by seven transmembrane helices, an extracellular N terminus, which is variable in length, and three extracellular loops (ECLs) (Fig. lA) . The structure of the co-receptor has not been determined, but some insight has come from the crystal structures of other family members (4) .
Elements critical to interactions with HIV-I are located in the co-receptor N terminus and around its second extracellular loop (ECL2) (5-8 co-receptor N terminus interacts with a highly conserved 4-stranded bridging sheet in gp120, which assembles upon CD4 binding, whereas the ECL2 region of the co-receptor interacts with the tip of the irnmunodominant V3 loop in gp120. Considerable distance separates these two interactive regions, which suggests that they are independent (9) (10) (11) (12) .
The N-terminal interaction of co-receptor with HIV-I requires an unusual posttranslational modification, O-sulfation of tyrosine (13) . On CCRS, tyrosines at residues 3, 10, 14, and IS may be O-sulfated, but sulfations at residues 10 and 14 are sufficient to facilitate interaction with HIV-I (14). Interestingly, many CD4-induced antibodies that react with the bridging sheet region are also modified by O-sulfation (15) . To define structurally the interaction of HIV-l with the N terminus of CCRS and to understand the molecular details of the mimicry of this interaction by CD4-induced antibodies, we used a combination of nuclear magnetic resonance (NMR) and x-ray crystallography to determine the structures of the N terminus of CCRS and of a functionally sulfated antibody, 412d, in complex with HIV-l gp120. Analysis ofthese structures, combined with molecular docking and saturation transfer difference NMR, identified a conserved site on gp 120, which recognizes sulfotyrosine with high selectivity.
We used NMR techniques that exploit the transfer of information from bound to ligand-free states (16, 17) to analyze the interactions of a 14residue peptide (CCRS 2 -15 ), which consisted of residues 2 to IS of CCRS with sulfotyrosine (Tys) at positions 10 and 14 ( Fig. I) (18) . We collected two-dimensional (2D) nuclear Overhauser enhancement spectroscopy (NOESY) spectra of solutions containing CCRS 2 -15 either free or in the presence of gp120, CD4, or a gp120-CD4 complex (peptide:protein ratio of 40:1). Whereas spectra containing free CCRS 2 -15 or CCRS 2 -15 with either gpl20 or CD4 contained few cross peaks, CCRS 2 -15 in the presence of the gp120-CD4 complex gave rise to high-quality spectra containing nwnerous NOEs ( Fig. lB and  fig. S1 ). Complete IH, 13C, and 15N assignments ofCCRS 2 -15 (table SI) were made on the basis of standard 2D homonuclear and heteronuclear NMR experiments that measure scalar and dipolar couplings.
The NOESY data of CCRS 2 -15 in the presence of gp120-CD4 ( Fig. lB) were sufficient for calculating a high quality ensemble of NMR structures (Fig. 1C ). Structure calculations were carried out on the ordered region comprising residues 7 to IS. A total of70 distance restraints (corresponding to 3S intraresidue and 3S interresidue NOEs), and S6 dihedral angle restraints were included in the final round of structure calculations, which gave rise to an ensemble of 40 structures with a backbone root-mean-square deviation (rmsd) of0.46 A and an rmsd of 1.39 A for all atoms in the ordered region (residues 9 to 14) (table S2). Superpositions of the fmal ensemble defined a helical conformation for residues 9 to IS, which deviated from the ideal by a backbone rrnsd of only 0.26 A (Fig. lD) . Sulfotyrosines 10 and 14 extended from the same face of the helix, with sulfate moieties separated by~loA and an~90°rotation around the helix axis.
We were unable to obtain crystals ofCCRS 2 -15 in complex with HIV-l gpI20-CD4, and the size and glycosylation of the ternary complex hindered direct determination by NMR. We were, however, able to obtain~3.S A diffraction from crystals of the antigen-binding fragment (Fab) of the 412d antibody, in complex with gp120 (core with V3, CCRS-dependent isolate YU2) and CD4. The 412d antibody is functionally tyrosinesulfated, binds to a CD4-induced epitope that overlaps the site of co-receptor binding on HIV-I gp120, and recognizes preferentially CCRSdependent strains ofHIV-l gpl20 (15) . Moreover, the tyrosine-sulfated region of 412d can be sub-1930 stituted for the tyrosine-sulfated region of CCR5 to create a chimeric 412d/CCRS receptor that supports HIV-1 entry (19) .
We solved the 412d-gp120-CD4 structure by molecular replacement. Despite less than optimal resolution and completeness, initial unbiased maps showed clear defmition of important antibody features ( fig. S2 ). Structure refmement resulted in an ReryS! of 20% (Rfree 27%) (Fig. 2,   table S3 , and fig. S3 ). The overall mode of binding of 412d resembles that of 17b, which shares a heavy chain of similar genomic origin ( fig. S4) (20) . A hydrophobic interaction pins the second complementarity-determining region of the heavy chain (CDR H2) to a conserved hydrophobic surface on the bridging sheet of gp120, whereas the acidic CDR H3 binds a basic gp 120 surface. Antibody 412d, however, interacts with a much larger overall surface area than either 17b or X5 ( fig. S4 ). The increased 412d interaction surface is due primarily to an increase in buried surface associated with its CDR H3. Comparison of free (20) and bound structures of 412d shows that extensive ordering occurs in CDR H3 when bound to gp120 ( fig. S5 ).
The two sulfotyrosines in the CDR H3 region of 412d bind to gp120 in quite different ways (Fig. 2) . The sulfotyrosine at residue 100 of412d (Tys 100 412d ) [Kabat numbering (21) ] is mostly exposed, with its aromatic ring making 1t-cation interactions with the guanidinium of Arg 327gp120 and its sulfate group making only peripheral electrostatic interactions. By contrast, the side-chain ofTys 100C 412d is mostly buried, in the presence of 20~M gp120-CD4 and were recorded at 500 MHz, 300 K, mixing time = 150 msec. Sequential NH(O-(aH(i-1) NOEs were observed between every residue, thereby confirming sequential assignments, and predicted intra residue NOEs were observed for all residues. No correlations beyond sequential NOEs were observed between residues 2 and 7, indicating that this region of CCRS was extended or disordered. In contrast, NOEs from CaH(Ii to NH(i + 1,2,3) and from NH(Ii to NH(i + 1,2,3) were observed for residues 9 to 15 (fig. 51) , indicating an ordered a-helical structure (33) . CD4 is yellow, the heavy chain of Fab 412d is dark blue, the light chain is cyan, and gp120 is gray, except for the V3 loop, which is orange. The CDR H3 loop of 412d is red, with sulfotyrosines depicted in stick representation. (8) Close-up, with molecular surface of gp120 in gray and sulfotyrosines of 412d (red labels) and select residues of gp120 (black labels) in stick representation. Dotted lines represent coordinating hydrogen bonds between gp120 and the sulfate group of Tys100C 412d . The sulfate of Tys 100C 412d makes a full complement of ionic interactions: a salt bridge to Arg 2989P120 and hydrogen bonds to the side-chain nitrogen of Asn 3029P120, the side-chain hydroxyl of Thr 3039P120, and the main-chain amides of 3029P120, 3039P120, and 4419P120 (34) . Despite initial random orientations, all favorable docking solutions had Tys 14 binding at the bridging sheet-V3 interface; none had Tys 10 at this cleft. Ribbon representations illustrate CD4 in yellow, gp120 in gray (with V3 in orange), and the lowest energy structure of CCRS7-15 in purple. (8) Close-up, with molecular surface of gp120 in gray and select residues of gp120 (black labels) and CCRS (purple labels) in stick representation. (() Saturation transfer difference NMR spectrum of CCRS 2 -15 in the presence of gp12Q-CD4 (red) overlaid on a control 1H spectrum (black). Experimental conditions were identical to those used for NOE experiments, except that the carrier was set at -1 and SO parts per million for on-and offresonance saturation, respectively. The intensities of the most strongly enhanced peaks (Tys 14 and Tyr 1S) have been normalized to the corresponding signals in the control spectrum. Peak assignments made by 2D NMR (table 51) fig. 59 for overlaid spectra employing 1 to 7 s saturation. (D) Effect of CCRS 2 -15 on the proteolytic sensitivity of the V3. Electrophoresis on an 8 to 2S% gradient SDS polyacrylamide gel shows the results of thrombin digestion on gp120 (core with V3; YU2 RS strain of HIV-1) alone, or in the presence of sCD4 or sCD4 and CCRS 2 -15 (35) . (E) Structural intermediates of HIV-1 entry. At far left, a single monomer of unliganded gp120 (gray) is shown with separated [3-hairpins. The threefold axis, from which gp41 interacts in the functional oligomer, is labeled with the number 3. In the CD4-bound state, the bridging sheet assembles, and the V3 (orange) is exposed and flexible. The next state involves either (upper pathway) the interaction of the CCRS-ECL2 region with the V3 tip or (lower pathway) the interaction of the CCRS N terminus, which induces rigidification of the V3 stem. Engagement of CCRS at both N terminus and ECL2 region triggers additional conformational changes leading to HIV-1 entry.
Bound V3 Unbound V3 Fig. 4 . A conserved site for binding sulfotyrosine on HIV-l gp120. (A) Alterations of the V3 base to accommodate binding of sulfotyrosine. The gp120 (gray) region around the V3 loop (orange) is illustrated in ribbon diagram, with an overlying semitransparent surface for unbound (left paneO and bound (right paneO conformations. Binding of the CCR5 N terminus (purple) or the 412d CDR H3 (red), each with two sulfotyrosines (stick representation, with red and purple labels), alters the V3 base, forming a sulfotyrosine binding pocket and a rigid~-hairpin. (B) Close-up of the conserved sulfotyrosine binding pocket. The orientation shown is similar to that in Figs. 2B and 3B [-90°from (A) about a diagonal axis, as defined by the long axis of the V3 from (A)]. Tys 14 CCR5 is shown in purple, with Tys 100C 412d in red. Select residues of gp120 are shown in stick representation and labeled in black. Hydrogen bonds coordinating the buried sulfate groups in each are depicted with dotted lines. 322 gp120 shifts 10 A to encase the 100C 412d tyrosine ring. Overall, the incoming and outgoing strands ofthe V3 stem are brought closer together, so that a~-hairpin is formed that replaces the previously flexible V3 stem (23) . Thus, whereas most of the gp120-CD4 complex remains unchanged, binding of sulfotyrosine at the bridging sheet-V3 interface results in formation ofa more rigid V3.
By employing molecular docking and saturation transfer difference NMR, we sought to use the 4l2d-gp120-CD4 structure to ascertain how gp120 interacts with the N terminus of CCRS. We fIrst tested whether docking [Autodock 3.0 (24)] of the CDR H3 loop of 4l2d to gp120 would recapitulate the 4l2d-gp120 crystal structure. Starting from random initial positions and orientations, multiple runs of the excised CDR H3 loop (residues 97 to lOOt) produced an energetically favorable interaction (-16.04 kcal/mol), which closely resembled its location and contacts in the crystal structure (Co rmsd between crystal and docked CDR H3 was 1.03 A) (fIg. S6). We next docked the NMR structure of the CCRS N terminus to the crystal structure of gp120-CD4. Multiple runs produced a cluster of energetically favorable solutions (-17.60 kcal/mol for the optimal solution), which placed CCRS 2 -15 at the bridging sheet-V3 interface (Fig. 3, A and B) . The top 10% of the solutions (20 best solutions from 200 runs) had rmsds of 1.04 A (Co) and 2.24 A (all atoms).
To validate the docked CCRS-gp120 structure, we performed saturation transfer difference NMR (17) on CCRS 2 -15 in the presence of gp120-CD4.
Control and difference spectra are shown in Fig. 3C . Contact surfaces ofTys and Tyrresidues ofCCRS in the docked orientation correlated well with saturation transfer difference enhancements (Fig. 3C) . We also observed good correlation between interacting residues in the docked gp120-CCRS interface and gp120 and CCRS substitutions (9, (25) (26) (27) that affect gp120-CCRS binding (fIg. S7) .
The N terminus of CCRS approaches from the same face of gp120 as CD4 but binds to an orthogonal surface at the intersection of the bridging sheet and the V3 loop (Fig. 3) . The fust CCRS residues (Ser 7 and Pro 8) that are ordered in the NMR structure interact with the V3 stem.
In the helix (residues 9 to IS), Tys 10 interacts with the gp120 core and forms a salt bridge with Arg 327gp120, Asp 11 forms an ionic interaction with Arg 440 gp120 , Tys 14 is completely sequestered in the crevice between V3 and the bridging sheet, and the aromatic ring of Tyr IS packs against Ile 439 gp 120 on the bridging sheet.
The structural rearrangements required to form the Tys 14 binding pocket would be expected to rigidifY the V3 stem. We tested V3proteolytic susceptibility (Fig. 3D ). CD4 enhances V3-proteolytic susceptibility to thrombin (28, 29) , whereas the combination ofCD4 and CCRS 2 -15 reduced proteolytic susceptibility (Fig. 3D) , consistent with CCRS-rigidifIcation ofV3.
Overall, the gp120 recognition surface for CCRS 2 -15 is much more highly conserved for CCRS-dependent isolates compared with those that use CXCR4. Good electrostatic complementarity is found between the acidic CCRS 2 -15 and gp120, where the negatively charged Cterminal helix dipole is oriented toward the basic bridging sheet (fIg. S8) . The docked structure provides an explanation for the observed lack of order at the N terminus ofCCRS 2 -15 , where CCRS appears to extend away from gp120. At the C terminus, Tyr IS points toward the target cell membrane where, in fIve residues, a disulfIde would normally be made between the N terminus (Cys 20) and the third extracellular loop (Cys 269).
Despite the higWy divergent tyrosine-sulfated structures of 4l2d and CCRS, a single sulfotyrosine (residue 100c in 4l2d and residue 14 in CCRS) is recognized in a similar manner by gp120 ( Fig. 4 ). We used mutagenesis to probe the degree of similarity in this recognition (fIg. S10) . The alteration of a single nitrogen in a contact residue (Asn302Asp) in the conserved binding pocket ablates recognition of both 4l2d and CCRS, whereas a similar substitution (Asn300Asp), just outside the binding pocket, had little effect (30) . The observed convergence of recognition likely reflects the high selectivity of this site for sulfotyrosine (a 7 A deep pocket, with hydrophobic walls and a cationic floor, which is unlikely to interact favorably with other nonmodifIed amino acids). Such selectivity and favorable energetics bode well for design of therapeutics targeted at this site, because the gp120 residues that line the sulfotyrosine binding pocket are highly conserved for co-receptor binding.
The structure of the CCRS N terminus with gp120-CD4 provides a further snapshot of the HIV-l entry pathway (Fig. 3E ). Before binding CD4, the bridging sheet is not formed and the V3 loop is occluded. Binding ofCD4 induces bridging sheet assembly and V3 exposure. At this stage, the V3 is flexible and poised close to the target cell membrane. Subsequent interactions with CCRS are still being elucidated. We show structural details for one: engagement by gp 120 of the CCRS N terminus, which requires formation ofa conserved pocket for sulfotyrosine binding and converts the flexible V3 stem into a rigid~-hairpin. It will be interesting to integrate the order and timing of the rearrangements revealed here into the HIV-l entry mechanism.
